IL-27 receptor signaling was recently found to play a key role in the stimulation of CD8+ T-cell anti-EBV responses, as congenital biallelic loss-of-function variants in the IL-27 receptor alpha chain are associated with severe primary EBV infection. Here, CD8A is linked to Epstein-Barr virus infection.